NCT02517034View on ClinicalTrials.gov

Geriatric Assessment in Predicting Chemotherapy Toxicity and Vulnerabilities in Older Patients With Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

August 4, 2015

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Solid Neoplasm
Interventions
OTHER

Comprehensive Geriatric Assessment

Follow geriatric assessment-driven treatment plan

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Survey Administration

Ancillary studies

Trial Locations (5)

91010

City of Hope Medical Center, Duarte

91030

City of Hope South Pasadena, South Pasadena

91730

City of Hope Rancho Cucamonga, Rancho Cucamonga

91790

City of Hope West Covina, West Covina

93534

City of Hope Antelope Valley, Lancaster

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT02517034 - Geriatric Assessment in Predicting Chemotherapy Toxicity and Vulnerabilities in Older Patients With Cancer | Biotech Hunter | Biotech Hunter